Baseline | 4-weeks | 12-weeks | 18-weeks | 24-weeks | p value | |
---|---|---|---|---|---|---|
Primary Outcome Measure | ||||||
FIQ | 59.26a | 37.16b | 40.36b | 42.04b | 43.95b | 0.006 |
Secondary Outcome Measures | ||||||
PVAQ | 40.57a | 32.71b | 26.71b | 26.71b | 26.57b | 0.003 |
PCS | 20.84a | 10.43b | 8.86b | 8.29b | 10..28b | 0.006 |
NRS | ||||||
Overall Quality of Life | 3.14a | 6.00b | 6.14b | 6.00b | 5.00b | 0.01 |
Overall Fibromyalgia Pain | 7.00a | 4.00b | 4.29b | 4.42b | 4.85b | 0.001 |
Overall Bone and Joint Pain | 8.00a | 4.14b | 5.14b | 4.86b | 5.14b | 0.004 |
Overall Non-Specified Pain | 5.57a | 4.00a,b | 3.28b | 3.42b | 3.87b | 0.033 |